Researchers at Johannes Gutenberg University Mainz Have Published New Study Findings on Glioblastomas (Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in...).

Keywords: Alcohols; Alkylating Agents; Amino Alcohols; Antineoplastics; Cancer; Caspase; Chemotherapy; Drugs and Therapies; Enzymes and Coenzymes; Genetics; Glioblastomas; Glycols; Health and Medicine; Kinase; Oncology; Pharmaceuticals; Sphingosine; Stem Cell Research; Temozolomide Therapy EN Alcohols Alkylating Agents Amino Alcohols Antineoplastics Cancer Caspase Chemotherapy Drugs and Therapies Enzymes and Coenzymes Genetics Glioblastomas Glycols Health and Medicine Kinase Oncology Pharmaceuticals Sphingosine Stem Cell Research Temozolomide Therapy 1069 1069 1 09/04/23 20230905 NES 230905 2023 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Investigators discuss new findings in glioblastomas. For more information on this research see: Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion. [Extracted from the article]